Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Takeda at: AE.GBR-IRL@takeda.com.

START WITH ONE - Paediatric Patient Selection & Initiation - Chaptered Video (16mins)

Watch this video featuring Susan Hill, Hannah Littlechild and Sophie Montgomery-Stuart, on how to select, counsel and initiate Revestive®▼ (teduglutide) in children with SBS-IF. Including insights and personal experiences from a patient's mother. This video describes:

1. An Overview of Revestive for Short Bowel Syndrome: The video provides information on how to select, counsel, and initiate Revestive treatment in children with short bowel syndrome-associated intestinal failure (SBS-IF)

2. Practical Guidance and Support: The video outlines the practical steps for starting a child on Revestive, emphasising the importance of a multidisciplinary team, proper training for families, and close monitoring during the initial stages of treatment.

3. Patient and Family Experience: It includes personal accounts from healthcare professionals and a patient's parent, discussing the challenges of managing SBS-IF and the positive impact of Revestive on the child's quality of life and overall health.

C-APROM/GB/REV/0305 Date of preparation March 2025